Spots Global Cancer Trial Database for Clinical Application of Lutetium [177Lu]-Catalase in Tumor Radionuclide Therapy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Clinical Application of Lutetium [177Lu]-Catalase in Tumor Radionuclide Therapy
Official Title: Clinical Application of Lutetium [177Lu]-Catalase in Tumor Radionuclide Therapy
Study ID: NCT05985278
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to evaluate the retention in tumour and distribution behavior of \[Lu-177\]-Catalase after intratumoral injection,and preliminary evaluation the efficacy and safety of \[Lu-177\]-Catalase.
Detailed Description: After being informed about the study and potential risks, all patients giving written informed consent will undergo a 2-week screening period to determine eligibility for study entry. At day1, patients who meet the eligibility requirements will be intratumoral injection the \[Lu-177\]-Catalase.The efficacy evaluation will be conducted at one month p.i., whether to continue intratumoral injection the \[Lu-177\]-Catalase, depending on the patient's efficacy and safety results.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Zhi Yang, Beijing, Beijing, China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
